Craven House Capital Regulatory News (CRV)

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

Craven House Capital plc

("Craven House" or the "Company")

Board Change

The Company announces that Mr. Richard Burrows' two-year appointment to the Board of Craven House has now come to an end. Mr Burrows has therefore stepped down as a director and Chairman of Craven House as of today's date. Mr. Mark Pajak will act as interim Chairman until the appointment of a new Chairman. The Board would like to express its sincere appreciation to Mr. Burrows for his invaluable support and guidance over the past two years.

~ Ends ~

For further information please contact:

About Craven House Capital:

The Company's Investing Policy is to invest in or acquire a portfolio of companies, partnerships, joint ventures, businesses or other assets globally in any geographic jurisdiction. The company will invest in both developed and developing markets providing long term patient capital and is often involved in special situations, restructuring, expansion and turn around investments in crisis and transitioning economies.